Core capability
Regulatory Affairs
Market-entry strategy, classification, dossier preparation, submission coordination and lifecycle support across complex regulated categories.
Global regulatory consulting
Global regulatory expertise.Local execution where it matters.
Genedrift helps pharmaceutical, biotechnology, medical-device and life-sciences organizations navigate complex regulatory markets through integrated Regulatory Affairs, Pharmacovigilance, MAH support and Regulatory Intelligence.
Not sure where to start?Explore by business need01Regulatory Affairs
02Pharmacovigilance
03MAH & Local Representation
- 1000+
- Regulatory submissions
- 500+
- PV deliverables
- 30+
- Markets supported
- 20+
- MAH markets
Featured Expertise
Explore all expertise Integrated expertise across the regulatory lifecycle.
Strategic interpretation and hands-on execution stay connected, so each market decision has a clear pathway and accountable owner.
Explore capability
Core capability
Pharmacovigilance
Integrated safety operations, compliant oversight and market-specific pharmacovigilance support across active product portfolios.
MAH & Local Representation
Accountable in-country representation, governance and lifecycle ownership.
Regulatory Intelligence
Structured monitoring translated into decision-ready market insight.
Managed Regulatory Services
Scalable, governed support across submissions and portfolio operations.
Dedicated Regulatory Teams
Experienced capacity that works within your operating model and standards.
Explore Business Needs
Start with the regulatory problem, not the service catalogue.
Choose the business situation closest to yours. The pathway connects the decision to the regulatory capabilities needed to move forward.
Market-entry pathway
Enter a New Market
Clarify classification, local representation, evidence and submission requirements before committing resources.
- Regulatory strategy
- Market intelligence
- MAH / local representation
Market-entry pathway
Enter a New Market
Clarify classification, local representation, evidence and submission requirements before committing resources.
- Regulatory strategy
- Market intelligence
- MAH / local representation
Explore Markets
Local intelligence. Regional control. Global consistency.
Explore active and upcoming Genedrift markets across Asia Pacific, the Middle East, Africa and CIS.
Active market Selected Upcoming Non-operational
Latest Regulatory Intelligence
View all intelligence Market change, interpreted for action.
Regulatory updateSaudi Arabia
Saudi Arabia updates requirements for pharmaceutical submissions
Market intelligenceIndia
Preparing for an evolving digital submission environment in India
PV briefingAfrica
Designing pharmacovigilance oversight across multi-country portfolios
Operational noteCIS
Local representation considerations for expanding into CIS markets
Featured Insights
Explore the Knowledge Hub Perspectives for confident regulatory decisions.
Regulatory strategy
Navigating multi-country regulatory submissions in emerging markets
A practical framework for aligning evidence, sequencing and local execution across diverse authority environments.
Read insightPharmacovigilance02
Building scalable pharmacovigilance across diverse regulatory environments
How to create consistent safety governance without losing essential local market accountability.
Market entry03MAH and local representation: choosing the right market-entry structure
Key operating questions for organizations establishing regulated product presence in a new jurisdiction.
Client Success Highlights
Complex engagements. Clear operating outcomes.
Representative engagement patterns are presented without exposing client-sensitive details or unsupported claims.
Leading Consumer Healthcare Company
- Context
- A growing portfolio required coordinated regulatory and pharmacovigilance support across several emerging markets.
- Engagement
- Genedrift established regional governance, local market ownership and a consistent delivery rhythm.
- Outcome
- The client gained one accountable operating view across regulatory and safety activities.
Leading US Regulatory Consulting Organization
- Context
- A trusted advisory partner needed dependable in-market execution without expanding permanent regional infrastructure.
- Engagement
- Genedrift provided dedicated local expertise, submission coordination and controlled client communication.
- Outcome
- Regional work moved through a clearer, scalable and fully governed delivery model.
Multinational Regulatory Intelligence Program
- Context
- Decision-makers needed relevant regulatory changes from multiple markets in one usable format.
- Engagement
- Genedrift designed a monitoring, interpretation and reporting process aligned to portfolio priorities.
- Outcome
- Market signals became a consistent input to regulatory planning and leadership decisions.
Industry / Product Expertise
Specialist support across regulated product categories.
Category knowledge remains connected to local market requirements, submission pathways and lifecycle obligations.
Pharmaceuticals
Prescription, OTC and complex portfolios
Medical Devices
Classification, registration and lifecycle
Food Supplements
Market pathway and compliance support
Cosmetics
Notification, claims and local requirements
Veterinary Products
Regulatory planning and market support
Supporting experience: Biologics · Biosimilars · Vaccines
Why Genedrift
A delivery model designed for trust, control and continuity.
Fully In-House Delivery
Local Expertise & Zero Subcontractors
Regional Project Management
Flexible Engagement Models
Integrated Regulatory & PV
Scalable Delivery
Quality-Driven Execution
Long-Term Partnership Approach
Global Presence
Global expertise. Local execution.
Regional project management brings market-specific work into one coherent delivery view while preserving local regulatory accountability.
4Operating regions
30+Priority markets
APAC
India · Singapore · Malaysia · Thailand · Vietnam
Middle East
Saudi Arabia · UAE · Qatar · Oman · Kuwait
Africa
Nigeria · Kenya · Tanzania · South Africa · Ghana
CIS
Kazakhstan · Uzbekistan · Azerbaijan · Kyrgyzstan
Speak to an Expert
Navigate your next regulatory challenge with confidence.
Tell us the market, product category or operating challenge you are planning around. We will help clarify the right path forward.
Direct specialist response Confidential initial discussion Market-specific guidance